Listen Later at your Convenience!
Watch one of our recorded presentations at your own leisure. Recorded presentations can be viewed by clicking on the desired session below.
Stay up to date and learn from experts in the field with our Tune in on Tuesday webinar series. NDCI features a new and exciting webinar, one Tuesday per month at 2:00 EST. Register today for an upcoming webinar!
Tune-In on Tuesday Webinar Series Archives:
Presented by Dr. Robert Dupont
March 25, 2014
Drugged driving, or driving impaired by the use of drugs other than alcohol, now rivals drunk driving as a major highway safety threat. There are an estimated 1.2 million annual arrests for driving under the influence (DUI), making drugged driving a significant law enforcement concern and providing a potential new pathway for drugged drivers to treatment and recovery. The science, law enforcement, treatment, and drug testing communities have made impressive strides in meeting this growing community threat. Returning veterans, many of whom face co-occurring diagnoses, including substance use disorders, are substantially at risk for drugged driving. Robert L. DuPont, M.D., the first director of the National Institute on Drug Abuse and former White House drug policy director discusses the current knowledge about drugged driving and what can be done to reduce this serious problem focusing on the important role of Drug Courts and the criminal justice system linked to substance abuse treatment.
Click here to watch the recording
Prescription Drug Monitoring Programs: Current and Potential Use in Drug Court Case Management
Presented by Dr. Grant Carrow and Judge Charles Hickman
March 21, 2014
Drug court use of reports from state prescription drug monitoring programs (PDMPs) is an emerging application of PDMP information to address prescription drug diversion and abuse. Most states have PDMPs, which provide authorized end users with reports consisting of a patient’s prescription history for controlled substances. Eight states’ PDMPs can provide drug courts with PDMP reports for case management of drug court participants.
This webinar will explore how PDMP reports are currently being used for case management in drug courts as well as potential uses in the future. The session will provide background on the prescription drug abuse epidemic, explain what PDMPs are and how they work, review the status of states with PDMPs generally, focus on those state PDMPs that provide access to drug courts and review the legal mechanisms used by states for drug court access to PDMP information. The webinar will also explore the use of PDMP information in case management through review of different use cases, discussion of a case study from one drug court and review of trends in use of PDMP information by Kentucky drug courts. Finally, the session will provide information on how drug courts can work with state PDMPs to gain access to PDMP information.
Know Who They Are and What They Need: Screening and Assessment for Co-Occurring Disorders
Presented by Dr. Roger Peters
May 28th, 2013
The relationship between substance use and mental disorders is complex and critical. Rates of these disorders in criminal justice settings are much higher than in the general population, and there many drug court participants have co-occurring disorders. Drug Courts are uniquely positioned to effectively intervene with persons who have co-occurring disorders. An important first step in developing specialized interventions for co-occurring disorders is to provide integrated screening prior to drug court entry. More in depth assessment of co-occurring disorders following program entry allows for rapid triage to specialized treatment interventions, case management, and supervision. This webinar will examine validated screening and assessment instruments for co-occurring disorders, strategies to determine eligibility for drug courts, and approaches for placement in specialized drug court services.
At the end of this webinar, participants will be able to:
• Describe several challenges in conducting screening and assessment of co-occurring disorders in drug courts
• Identify several instruments to screen and assess for co-occurring disorders, including instruments examining major mental disorders, substance dependence, PTSD/trauma, and criminal risk
• Understand basic strategies to screen and assess for drug court eligibility
• Make adaptations to drug court assessment procedures to address co-occurring disorders
Expanding Your Treatment Options for Individuals with Co-Occurring Disorders
Presented by Dr. Kim Mueser
May 21, 2013
Research shows that the expansion of treatment options is critical to addressing individuals with co-occurring disorders in the criminal justice system. This module is designed to provide drug court professionals with information about specific treatment approaches to include in their programs to assist those with co-occurring disorders.
At the end of this module, participants will be able to:
· Describe the new definition of recovery from mental illness
Identify evidence-based and promising treatment approaches for the co-occurring population
· Discuss how to improve individual treatment plans
Effective Alcohol Treatment: Doing the Right Thing the Right Way
Presented by Terrence Walton
April 2, 2013
This webinar discusses the importance of evidence-based alcohol treatment in the DWI Court model challenging DWI Court teams to look at what approaches they are currently using. DWI Courts need to make sure every participant is getting effective alcohol-related treatment based on the research. Evidence-based treatment approaches and community support options will be examined with recommendations on what steps should be taken to develop a more effective treatment program in a DWI Court.
Evidence Based Practices
Presented by Steve Hanson
March 26, 2013
Understanding the importance of being able to demonstrate the use of services validated by documented research is a necessity amongst drug court practitioners. This webinar is geared towards teaching viewers about evidence-based practices and where to locate information on proven services and methods. In addition, practitioners will learn how to determine which evidence-based practices are most appropriate for participants of their drug court programs.
Presented by Steve Hanson
March 12, 2013
Psychopharmacology is the study of the effects of drugs on behavior. Understanding these effects play a pivotal role in treatment implications amongst participants of drug court programs. This webinar will discuss the potential short and long term effects of alcohol and other drug use on brain physiology and behavior. Viewers of this session will be able to differentiate between substance abuse and dependence and understand the widespread physiological and psychological changes caused by alcohol and other drug use. The knowledge gained through this webinar will allow drug court practitioners to begin to develop appropriate and attainable expectations for participants of their programs.
2013 BJA Adult Drug Court Discretionary Grant Program
Presented by Sonya L. Harper
January 8, 2013
The U.S. Department of Justice (DOJ), Office of Justice Programs (OJP), Bureau of Justice Assistance (BJA) has released the Adult Drug Court Discretionary Grant Program FY 2013 Competitive Grant Solicitation to establish or enhance Drug Court services, coordination, offender management, and recovery support services.
Grants are open to Adult Drug Courts, examples of eligible programs include Driving While Intoxicated (DWI)/Driving Under the Influence (DUI) Courts, Veterans Treatment Courts, Reentry Courts, and Tribal Healing to Wellness Courts.
Category 1: Implementation Grants
Implementation grants are available to jurisdictions that have completed a substantial amount of planning and are ready to implement an evidenced based Adult Drug Court. Grant Maximum: $350,000. Project Period: 36 Months.
Category 2: Enhancement Grants
Enhancement grants are available to jurisdictions with a fully operational Adult Drug Court. Grant Maximum: $200,000. Project Period: 24 Months.
Category 3: Statewide Grants
Statewide grants are provided to (A) improve or expand Drug Court services statewide by encouraging adherence to evidence-based design features, and (B) financially support Drug Courts in local or regional jurisdictions which do not currently operate with BJA Adult Drug Court Discretionary Grant Program funding. Grant Maximum: $1.5 million (a maximum of $200,000 is available per applicant under category A, and a maximum of $1,300,000 per applicant under category B). Project Period: 36 months.
Applicants must register with Grants.gov prior to submitting an application. All applications are due by 11:59 p.m. EST on February 21, 2013.
NDCI through the National Drug Court Resource Center (NDCRC.org) will be hosting a webinar on January 8, 2013 to help courts complete the application.
2012 Revised SAMHSA Guidelines on EtG/EtS- What This Means for Drug Courts
Presented by Paul Cary
July 24, 2012
This webinar is designed to review the recently revised Advisory from SAMHSA entitled: "The Role of Biomarkers in the Treatment of Alcohol Disorders, 2012 Revision. Ethyl glucuronide (EtG) and ethyl sulfate (EtS) have become critical tests in the abstinence monitoring of alcohol in drug court settings. The original SAMHSA Advisory (September, 2006) caused a significant chilling effect on the utility of EtG/EtS testing and raised questions regarding the appropriate use of this valuable monitoring tool in a forensic context. Drug Courts have been anxiously awaiting these revisions. The following issues related to the revised advisory will be discussed during this webinar:
- Review of both indirect and direct alcohol biomarkers and their use
- Discussion of what alcohol biomarkers are most appropriate for use in therapeutic/treatment courts settings
- Evaluation of EtG/EtS cutoff concentrations appropriate for therapeutic/ treatment courts case adjudication
- Review of the importance of a client contract when utilizing EtG/EtS testing for alcohol abstinence monitoring
- Comparison of EtG/EtS testing methods
- Best practices for therapeutic/treatment courts using or planning to use EtG/EtS testing
Presented by Helen Harberts
July 10, 2012
Supervision is a critical element of your drug court model. Research has verified this key component is important for savings and outcome improvements. Frequent and extended supervision makes a difference to your clients. Learn what to look for, how to do it, and who to partner with in order to maximize your dollars and your outcomes. Fun, fast moving, and educational, this presentation is designed for community supervision practitioners so they can sharpen their skills and understanding of what makes a difference.
An Update from Washington: What National Health Reform Means for Drug Courts
Presented by Dan Belnap
June 26, 2012
The health care system in this country is currently in a period of tremendous change. Just over a year and half remains before the major provisions of the Affordable Care Act are scheduled to take effect, including historic expansions of coverage for substance use disorder services. These changes will have significant implications for the addiction treatment system, including for drug courts, and it is important for drug courts to be prepared for the opportunities and challenges presented by health reform. This presentation will give an overview of the Affordable Care Act and what it means for drug courts, including federal developments related to addiction treatment, the critical role of states to shape key components of the law, delivery system reforms, and opportunities available for improving health policy moving forward.
Alternative Tracks in Adult Drug Courts: Matching Your Program to the Needs of Your Clients
Presented by: Dr. Douglas Marlowe
April 17, 2012
More than two decades of research indicates which types of adult offenders are most in need of drug court services. Research shows that drug courts work best for offenders who are both high-risk and high-need. These high-risk and high-need offenders are in need of the full array of services embodied in the “10 Key Components” of drug courts. It may not always be possible or desirable for a drug court to target high-risk and high-need participants exclusively. In some communities the drug court may be the most effective, or perhaps only, program serving as an alternative to incarceration that has staff members with expertise in managing drug-involved offenders. This webinar will describe the conceptual framework and evidence-based practice recommendations for designing alternative tracks within a drug court to serve various types of adult participants.
Targeting the Right Participants for Adult Drug Courts
Presented by: Dr. Douglas Marlowe
April 3, 2012
Adult drug courts are not designed to treat all drug-involved adult offenders. They were created to fill a specific service gap for drug-dependent offenders who were not responding to existing correctional programs. Research shows that drug courts work best for offenders who are both high-risk and high-need. These high- risk and high- need offenders are in need of the full array of services embodied in the “10 Key Components” of drug courts. This webinar will go over research and evidence to assist programs with revisiting the target population for their drug court.
DWI vs. Drug Offender
Presented By: Dr. Kenneth Robinson and Judge Patrick Bowler
More and more Drug Treatment Courts are taking habitual DWI offenders into their programs raising questions on what is the proper treatment and supervision for this group of participants; should it be the same as the drug addicted participants? This webinar discusses the practical and theoretical reasons why some Drug Courts with DWI participants have created separate tracks for the courtroom as well as for treatment.
But I Got a Script For It
Presented By: Vanessa Price
Prescription drug abuse and addiction has traditionally been overlooked when considering its impact on criminal justice. National studies and published reports indicated that the abuse of prescription and over-the-counter (OTC) drugs is a growing concern. The impact of prescription drug abuse and addiction on the criminal justice system must be considered in the design of, target population, and service delivery in specialty courts.
Working Wounded: Avoiding and Coping with Professional Impairment
Presented By: Terrence Walton
This presentation explores the frequently overlooked issue of impairment in Drug Court professionals. All of us seek to balance the stresses and strains of our private lives with the need to perform effectively at work. Even in tough times most of us are able to “pull it together” long enough to get through our day. However there are times when issues such as divorce, disease, drinking, drugging, depression or other dysfunction rob us of our ability to do our jobs and/or find joy in doing so. Whether the problem results from an acute incident or from a chronic problem that has reached the breaking point, the consequences can be life and livelihood threatening. This presentation is essential for those who fear they may be impaired; want to know the warning signs of impairment; or want to know how best to support co-workers or loved ones who are struggling.
Post-Traumatic Stress Disorder (PTSD)
Presented By: Dr. Casey Taft
The first portion of this webinar will provide an overview of Post-Traumatic Stress Disorder (PTSD), including diagnostic features, the identification of biomarkers for PTSD, and interventions for PTSD. The second portion of the webinar will focus on how trauma and PTSD may impact the family and interventions to prevent family conflict and domestic violence will be discussed.
The Effective Use of Urine Creatinine Measurements in Abstinence Monitoring
Presented By: Paul Cary
The most common form of urine specimen tampering in drug court is sample dilution. The most effective strategy for combating this tampering technique is testing for urine creatinine. This webinar will focus on the importance of urine creatinine measurements adn interpretation of creatinine results. Specific gravity, inadvertent dilutes, high creatinine levels, medical conditions effecting creatinine and creatinine sanctioning options will all be discussed.
Presented By: Meghan Wheeler
Sustainability must be the focus of every member of the drug court team and it is vital to have a comprehensive funding strategy to ensure long-term survival. This webinar will identify various types of funding available to drug courts and identify the range of resources and options to support drug courts including sources of monetary and non-monetary resource.
How to Build a Mentor Program for your Veterans Treatment Court
Presented By: Jack O'Connor
A Veterans Treatment Court consists of the court itself, the VA, and Veteran Mentors. This session will help you understand and set up a mentoring program.
Bath Salts-Another Designer Drug
Presented By: Paul Cary
This session provides facts about these designer drugs including information on their origin, chemical composition, effects on humans, detection and the legal efforts to ban their sale.
Constitutional and Legal Issues
Presented By: Judge William Meyer (ret.)
This interactive session discusses what constitutional issues are currently being raised about Drug Court practices.
Incentives and Sanctions
Presented By: Dr. Douglas Marlowe
This presentation outlines the basic behavior modification principles and their applicability in sanctions and incentives. It identifies the importance of incentives, both formal and informal, and their application in the program.
Presented By: Terrence Walton
This fascinating session examines both the prevailing views of relapse and the multi-dimensional aspects of effective relapse prevention planning and programming.
Presented By: Paul Cary